Edition:
United States

CSL Ltd (CSL.AX)

CSL.AX on Australia Stock Exchange

206.42AUD
24 May 2019
Change (% chg)

$0.22 (+0.11%)
Prev Close
$206.20
Open
$206.40
Day's High
$207.71
Day's Low
$205.21
Volume
519,336
Avg. Vol
839,671
52-wk High
$232.69
52-wk Low
$173.00

About

CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment... (more)

Overall

Beta: 0.87
Market Cap(Mil.): $61,017.67
Shares Outstanding(Mil.): 452.59
Dividend: 0.92
Yield (%): 1.10

Financials

  CSL.AX Industry Sector
P/E (TTM): 35.86 29.30 32.55
EPS (TTM): 3.76 -- --
ROI: 19.53 14.23 13.82
ROE: 46.67 15.46 15.25

Australia shares steady ahead of Fed meeting; NZ down

March 19 Australian shares were little changed in thin trade on Tuesday, ahead of the U.S. Federal Reserve policy meeting later in the day, with healthcare stocks offsetting gains in the mining sector which was buoyed by robust iron ore prices.

Mar 18 2019

Australia shares dragged by CSL losses, NZ gains

Feb 13 Australian shares fell on Wednesday, erasing early gains as heavyweight drugmaker CSL dragged the index after posting a disappointing first-half profit rise.

Feb 13 2019

UPDATE 2-Investors impatient as Australia's CSL shows signs of slowing growth

* Company upgrades FY guidance to top of $1.88-1.95 bln range

Feb 12 2019

Australia shares gain on trade optimism, CSL falters after earnings; NZ up

Feb 13 Australian shares edged higher on Wednesday on hopes the United States and China might be able to hammer out a deal to ease their months-long trade war.

Feb 12 2019

Australia's CSL posts 10 pct increase in 1st-half profit

Feb 13 Australian pharmaceutical behemoth CSL Ltd said on Wednesday its first-half profit grew 10.1 percent following stronger drug sales in the United States, and raised its full-year guidance to the upper end of an earlier provided range.

Feb 12 2019

Australia shares hampered by CBA's disappointing results, financials fall

* Mining stocks jump to near 7-year high as Vale SA declares force majeure

Feb 05 2019

Earnings vs. Estimates